SCHEMBL4784027

SCHEMBL4784027

COc1cccc(CC(N)CN2C(=O)c3ccccc3C2=O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.55
KMT2A Q03164 2/20 0.54
ALDH1A1 P00352 2/20 0.54
KDM4E B2RXH2 1/20 0.54
MEN1 O00255 1/20 0.54
POLB P06746 1/20 0.54
MAPT P10636 1/20 0.54
HPGD P15428 1/20 0.54
MAPK1 P28482 1/20 0.54
ATM Q13315 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
NR1H2 P55055 1/20 0.52
NR1H3 Q13133 1/20 0.52
HEXA P06865 1/20 0.49
HEXB P07686 1/20 0.49
CMA1 P23946 1/20 0.49
GAA P10253 1/20 0.47
CASP3 P42574 1/20 0.47
ALPL P05186 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4899590 0.99 TAAR1 (0.54) TAAR1KMT2AALDH1A1KDM4EMEN1
SCHEMBL4582646 0.85 CASP3 (0.60) KMT2AKDM4EMEN1NR1H3GAA
SCHEMBL4582642 0.85 CASP3 (0.60) KMT2AKDM4EMEN1NR1H3GAA
SCHEMBL1529483 0.80 EPHX1 (0.53) ALDH1A1POLBMAPK1L3MBTL1GAA
SCHEMBL2370243 0.80 EPHX1 (0.53) ALDH1A1POLBMAPK1L3MBTL1GAA
SCHEMBL1529481 0.80 EPHX1 (0.53) ALDH1A1POLBMAPK1L3MBTL1GAA
SCHEMBL1529973 0.80 ACHE (0.53) KMT2AKDM4EMEN1MAPTHPGD
SCHEMBL20912948 0.80 UBE2N (0.47) KMT2AALDH1A1MAPK1CASP3ALDH3A1
SCHEMBL1529971 0.80 ACHE (0.53) KMT2AKDM4EMEN1MAPTHPGD
SCHEMBL676622 0.80 UBE2N (0.47) KMT2AALDH1A1MAPK1CASP3ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith D SIDOCKY NEIL R 2008-10-02 US disclosed
WO-2008036308-A2 AMINO-SUBSTITUTED HETEROCYCLES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2008-03-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242694-A1 Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith JAK2, CHEK2, MTOR TAAR1 2754/4885KMT2A 758/4885ALDH1A1 1752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.